Cullinan Therapeutics, Inc. (CGEM)

NMS – Real Time Price. Currency in USD

19.49

-0.14 (-0.74%)

Market open: Aug 12, 2026, 1:50 PM EDT

19.66

+0.03 (0.15%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-311K

-306K

-310K

-93K

Gross Profit

-311K

-306K

-310K

-93K

Operating expenses (excl. COGS)

-241M

-197M

-190M

-132M

Operating Income

-242M

-197M

-191M

-132M

Non-operating income, total

22M

29M

21M

283M

Pretax income

-220M

-167M

-169M

151M

Equity in earnings

Taxes

-117K

14M

-42M

Non-controlling/minority interest

192K

After tax other income/expense

Net income before discontinued operations

-220M

-167M

-153M

111M

Discontinued operations

Net income

-220M

-167M

-153M

111M

Dilution adjustment

Preferred dividends

Cullinan Therapeutics, Inc. (CGEM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Cullinan Therapeutics, Inc. (CGEM)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Cullinan Therapeutics, Inc. (CGEM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Cullinan Therapeutics, Inc. (CGEM)

Income Statement (Annual)

Income Statement (Annual)